Hair Regen Hair Regrowth Treatment

Manufacturer
YIWU YIZHOU TRADING CO.,LTD
Effective date
2025-01-08
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:51:07

Label at a glance#

ProductHair Regen Hair Regrowth Treatment
Active ingredientMINOXIDIL
Label structure12 sections

Dosage and administration

●Apply one mL. with dropper 2 times a day directly onto the scalp in the hair loss area. ●Using more or more often will not improve resufts. ●continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again.

Storage and handling

●See hair loss pictures on side of box ●Before use, read all information on box and enclosed instructions. ●Keep the box, it contains important information. ●Hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with minoxidil topical sol ution 5% for men. ●In Clinical studies with mostly white men aged 18-49 years with moderate degrees of hair loss, minox...

Label contents#

Full prescribing information#

Active Ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Minoxidil 5%

Purpose

OTC - PURPOSE SECTION

HAIR REGROWTH TREATMENT

Use

INDICATIONS & USAGE SECTION

USE to regrow hair on top of scalp (vertex only, see pictures on side of box)

Warnings

WARNINGS SECTION

For external use only. For use by men only.

Do not use

OTC - DO NOT USE SECTION

  • You are a woman.
  • Your amount of hair loss is different than that shown on the side of this carton or your hair loss is on the front of the scalp. Minoxidil topical solution 5% is not intended for frontal baldness or receding hairline.
  • You have no family history of hair loss.
  • Your hair loss is sudden and/or patchy.
  • You do not know the reason for your hair loss.
  • You are under 18 years of age. Do not use on babies and children.
  • Your scalp is red, inflamed, infected, rritated, or painful.
  • You use other medicines on the scalp.

When using this product.

OTC - WHEN USING SECTION

●Do not apply on other parts of your body.

●Avoid contact with the eyes. In case accidental contact, rinse eyes with large amounts of cool tap water.

●Some people have experienced changes in hair color and/or texture.

●It takes time to regrow hai, results may occur at 2 months with twice a day usage. For some men, you may need to use this product for at least 4 months before you see results.

●The amount of hair regrowth is different for each person. This product will not work on all men,

Stop use

OTC - STOP USE SECTION

●Chest pain, rapid heartbeat, faintness, or dizziness occurs

●Sudden, unexplained weight gain occurs

●Your hands or feet swell

●Scalp rritation or redness ocurs

●Unwanted facial hair growth occurs

●You do not see hair growth in 4 months

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep away from fire or flame

Directions

DOSAGE & ADMINISTRATION SECTION

●Apply one mL. with dropper 2 times a day directly onto the scalp in the hair loss area.

●Using more or more often will not improve resufts.

●continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again.

Other information

STORAGE AND HANDLING SECTION

●See hair loss pictures on side of box

●Before use, read all information on box and enclosed instructions.

●Keep the box, it contains important information.

●Hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with minoxidil topical sol ution 5% for men.

●In Clinical studies with mostly white men aged 18-49 years with moderate degrees of hair loss, minoxidil topical solution 5% for men provided more hair regrowth than minoxidil topical sol lution 2%

●Store at 20° to 25*C (68° to 77*F). Keep tightly closed

Inactive ingredients

INACTIVE INGREDIENT SECTION

alcohol, propylene glycol, purified water

Package Label - Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

undefinedundefinedundefinedundefined

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
311724minoxidil 5 % Topical SolutionPSN2
311724minoxidil 50 MG/ML Topical SolutionSCD2
311724minoxidil 3 GM per 60 ML Topical SolutionSY2
311724minoxidil 5 % Topical SolutionSY2
311724minoxidil 5 GM per 100 ML Topical SolutionSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84232-002-01Hair Regen Hair Regrowth Treatment60 mL in 1 BOTTLELIQUID602

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84232-002HAIR REGEN HAIR REGROWTH TREATMENT (MENS LIQUID MINOXIDIL 1PK) LIQUID [YIWU YIZHOU TRADING CO.,LTD]2Current NDC, 1 package rows20250109_29ae2b06-92ff-7a8b-e063-6294a90a2c7e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84232-00284232-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Hair Regen Hair Regrowth TreatmentMENS LIQUID MINOXIDIL 1PKYIWUYIZHOUTRADINGCO.,LTD29ae2b06-92ff-7a8b-e063-6294a90a2c7e2025-01-08WarningsExact identifier
ndc (package): 84232-002-01
ndc (product): 84232-002
ndc11 (package): 84232000201
spl id: 2b2e3eca-826c-e313-e063-6394a90abe03
spl set id: 29ae2b06-92ff-7a8b-e063-6294a90a2c7e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.